US STOCK
HALO Stock Analysis
US stocks · market data · technical indicators
Halozyme Therapeutics, Inc.
HALOUS stocksQuote delayed 15 min
10/26 下午12:53 updated
$125.63
+1.09+0.88%
Open
$124.54
High
$126.23
Low
$123.74
Volume
153.05萬
HALO price history
+11.29%Open
112.89
Latest
125.63
High
125.63
Low
106.94
Average
115.17
Advertisement
Financial snapshot
HALO - Halozyme Therapeutics, Inc.
EPS
3.42USD
Forward EPS
10.68USD
P/E
36.73x
Forward P/E
11.76x
P/B
99.79x
ROE
173.67%
ROA
25.49%
Operating margin
59.80%
Profit margin
24.86%
Revenue growth
47.70%
Earnings growth
42.90%
Dividend yield
0.00%
Financial statements
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| Revenue | $481.00M | $376.71M | $451.77M | $354.26M | $325.72M |
| Gross profit | $401.83M | $297.47M | $373.00M | $299.02M | $279.36M |
| Operating income | $287.65M | $184.52M | $240.70M | $217.92M | $202.44M |
| Net income | $229.91M | $150.05M | -$141.59M | $175.22M | $165.16M |
| Basic EPS | 1.96 | 1.27 | -1.20 | 1.49 | 1.36 |
| Diluted EPS | 1.90 | 1.22 | -1.20 | 1.43 | 1.33 |
Estimates vs actuals
Next earnings
2026-11-05
EPS estimate
2.35
Revenue estimate
$490.85M
Last surprise
+25.53%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-11-05 | 2.35 | Not reported | — |
| 2026-08-06 | 1.82 | 2.28 | +25.53% |
| 2026-05-11 | 1.52 | 1.60 | +5.26% |
| 2026-02-17 | 2.20 | -0.24 | -110.92% |
| 2025-11-03 | 1.63 | 1.72 | +5.51% |
| 2025-08-05 | 1.27 | 1.54 | +21.45% |
| 2025-05-06 | 0.95 | 1.11 | +17.14% |
| 2025-02-18 | 1.16 | 1.26 | +8.73% |
| 2024-10-31 | 1.00 | 1.27 | +27.05% |
| 2024-08-06 | 0.76 | 0.91 | +20.10% |
| 2024-05-07 | 0.70 | 0.79 | +13.57% |
| 2024-02-20 | 0.83 | 0.82 | -1.44% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| BlackRock Inc. | 2024-06-30 | $922.6M | 0.02% |
| VANGUARD GROUP INC | 2025-12-31 | $778.5M | 0.01% |
| STATE STREET CORP | 2026-06-30 | $405.4M | 0.01% |
| TWO SIGMA INVESTMENTS, LP | 2026-06-30 | $129.4M | 0.09% |
| RENAISSANCE TECHNOLOGIES LLC | 2026-06-30 | $37.5M | 0.05% |
| Bridgewater Associates, LP | 2026-06-30 | $36.3M | 0.15% |
| CITADEL ADVISORS LLC | 2026-06-30 | $22.6M | 0.00% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$108.78
Target range
$78.00 – $130.00
Implied upside
-13.41%
Strong buy
2
Buy
5
Hold
2
Sell
0
Strong sell
0
Advertisement